the present invention solves these problems by providing BPC peptide salts and a pharmaceutical or diagnostic composition comprising a pharmaceutically or diagnostically effective amount of the salts of BPC peptides said peptides being constituted of 8 to 15 amino acids, wherein the anion of the salt is a negatively charged peptide comprising 8 amino acid residues having the general formula (I) wherein Xaa is a neutral aliphatic amino acid residue, in particular Ala, bAla, Leu, Ile, Gly, Val, Nle or Nva, Yaa is a basic amino acid residue, in particular Lys, Arg, Orn or His and Zaa is an acidic amino acid residue, in particular Glu, Asp, Aad or Apm and wherein the cation of the salt is the cation of an inorganic or organic nontoxic and pharmaceutically acceptable base
Our programs include GLP-1S and GLP-1T, compounded versions of GLP-1 medications, all prescribed and monitored by our medical team
out of 128 eligible biologic molecules, only 12 have active biosimilar programs
If you have a qualifying comorbidity alongside obesity, work with your provider to make sure its documented that documentation could be the difference between covered and denied
For many people, nausea comes and goes
These three complementary mechanisms act synergistically with exogenous insulin to improve overall glycemic control while mitigating insulin-associated weight gain
